XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Total
Common Stock
Additional Paid in Capital
Retained Earnings (Accumulated Deficit)
Beginning Balances at Dec. 31, 2021 $ 47,118,097 $ 107,086 $ 46,851,360 $ 159,651
Beginning Balance, shares at Dec. 31, 2021   10,708,613    
Restricted stock grants issued   $ 260 (260)  
Restricted stock grants issued, Shares   26,025    
Restricted stock grant forfeiture   $ (2) 2  
Restricted stock grant forfeitures, shares   (203)    
Issuance of common stock, net of expenses 198,370 $ 659 197,711  
Issuance of common stock, net of expenses, Shares   65,843    
Stock-based compensation 52,604   52,604  
Net income 283,207     283,207
Dividends (700,339)     (700,339)
Ending Balance at Mar. 31, 2022 46,951,939 $ 108,003 47,101,417 (257,481)
Ending Balance, shares at Mar. 31, 2022   10,800,278    
Beginning Balances at Dec. 31, 2021 47,118,097 $ 107,086 46,851,360 159,651
Beginning Balance, shares at Dec. 31, 2021   10,708,613    
Net income 687,407      
Ending Balance at Jun. 30, 2022 47,672,934 $ 109,657 48,125,045 (561,768)
Ending Balance, shares at Jun. 30, 2022   10,965,680    
Beginning Balances at Mar. 31, 2022 46,951,939 $ 108,003 47,101,417 (257,481)
Beginning Balance, shares at Mar. 31, 2022   10,800,278    
Restricted stock grant forfeiture   $ (4) 4  
Restricted stock grant forfeitures, shares   (406)    
Issuance of common stock, net of expenses 985,953 $ 1,658 984,295  
Issuance of common stock, net of expenses, Shares   165,808    
Stock-based compensation 39,329   39,329  
Net income 404,200     404,200
Dividends (708,487)     (708,487)
Ending Balance at Jun. 30, 2022 47,672,934 $ 109,657 48,125,045 (561,768)
Ending Balance, shares at Jun. 30, 2022   10,965,680    
Beginning Balances at Dec. 31, 2022 $ 48,339,114 $ 111,091 49,029,712 (801,689)
Beginning Balance, shares at Dec. 31, 2022 11,109,077 11,109,077    
Restricted stock grants issued   $ 380 (380)  
Restricted stock grants issued, Shares   37,976    
Restricted stock grant forfeiture   $ (32) 32  
Restricted stock grant forfeitures, shares   (3,145)    
Stock-based compensation $ 37,787   37,787  
Net income 992,541     992,541
Dividends (805,228)     (805,228)
Ending Balance at Mar. 31, 2023 48,564,214 $ 111,439 49,067,151 (614,376)
Ending Balance, shares at Mar. 31, 2023   11,143,908    
Beginning Balances at Dec. 31, 2022 $ 48,339,114 $ 111,091 49,029,712 (801,689)
Beginning Balance, shares at Dec. 31, 2022 11,109,077 11,109,077    
Net income $ 1,570,611      
Ending Balance at Jun. 30, 2023 $ 48,378,272 $ 111,439 49,111,072 (844,239)
Ending Balance, shares at Jun. 30, 2023 11,143,908 11,143,908    
Beginning Balances at Mar. 31, 2023 $ 48,564,214 $ 111,439 49,067,151 (614,376)
Beginning Balance, shares at Mar. 31, 2023   11,143,908    
Stock-based compensation 43,921   43,921  
Net income 578,070     578,070
Dividends (807,933)     (807,933)
Ending Balance at Jun. 30, 2023 $ 48,378,272 $ 111,439 $ 49,111,072 $ (844,239)
Ending Balance, shares at Jun. 30, 2023 11,143,908 11,143,908